Circulating Follistatin Predicts Tirzepatide Treatment Outcomes on Type 2 Diabetes

被引：0
|
作者：
Zou, Qi
Engstrom, Gunnar
Pan, Jingxue
Zhang, Jialin
Perisho, Esther J.
Lin, Yanzhu
Wiese, Russell
Wilson, Jonathan M.
Pavo, Imre
Gao, Rui
Duffin, Kevin L.
De Marinis, Yang
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-741-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
741-P
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Surpassing insulin glargine in type 2 diabetes with tirzepatide
    Khoo, Bernard
    Tan, Tricia M-M
    LANCET, 2021, 398 (10313): : 1779 - 1781
  • [22] The effectiveness and value of tirzepatide for type 2 diabetes mellitus
    Nikitin, Dmitriy
    Lin, Grace A.
    Campbell, Jon D.
    Hansen, Ryan N.
    Brouwer, Elizabeth
    Chen, Yilin
    Herron-Smith, Serina
    Agboola, Foluso
    Pearson, Steven D.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2022, 28 (06): : 680 - 684
  • [23] Clinical Outcomes of Tirzepatide or GLP-1 Receptor Agonists in Individuals With Type 2 Diabetes
    Chuang, Min-Hsiang
    Chen, Jui-Yi
    Wang, Hsien-Yi
    Jiang, Zheng-Hong
    Wu, Vin-Cent
    JAMA NETWORK OPEN, 2024, 7 (08)
  • [24] Tirzepatide: A Promising Drug for Type 2 Diabetes and Beyond
    Dutta, Palak
    Kumar, Yashaank
    Babu, Alexis T.
    Ravindran, Suganya Giri
    Salam, Ajal
    Rai, Bhumish
    Baskar, Aakash
    Dhawan, Ananya
    Jomy, Manjima
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (05)
  • [25] Tirzepatide: A New Generation Therapeutic for Diabetes Type 2
    Al-Horani, Rami A.
    Chedid, Milad
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2023, 23 (08) : 1046 - 1050
  • [26] Follistatin linked to type 2 diabetes mellitus risk
    Tysoe O.
    Nature Reviews Endocrinology, 2022, 18 (2) : 69 - 69
  • [27] Early weight loss and late metabolic outcomes in tirzepatide-treated participants with type 2 diabetes
    Van Gaal, L. F.
    Lingvay, I.
    Giorgino, F.
    Liu, M.
    Rodriguez, A.
    Torcello-Gomez, A.
    Kiljanski, J.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S334 - S334
  • [28] Effect of tirzepatide on the risk of diabetic retinopathy in type 2 diabetes
    Popovic, Djordje S.
    Patoulias, Dimitrios
    Karakasis, Paschalis
    Koufakis, Theocharis
    Papanas, Nikolaos
    DIABETES OBESITY & METABOLISM, 2024, 26 (06): : 2497 - 2500
  • [29] Efficacy and Safety of Tirzepatide in Type 2 Diabetes and Obesity Management
    Sinha, Rachel
    Papamargaritis, Dimitris
    Sargeant, Jack A.
    Davies, Melanie J.
    JOURNAL OF OBESITY & METABOLIC SYNDROME, 2023, 32 (01) : 25 - 45
  • [30] Tirzepatide versus Semaglutide Once Weekly in Type 2 Diabetes
    Frias, Juan P.
    Lando, Laura Fernandez
    Brown, Katelyn
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (07):
12345